Nuvation Bio CFO Jennifer Fox resigns effective Nov 27

Nuvation Bio Inc.

CFO Jennifer Fox resigns to pursue a new opportunity; not due to any disagreement with the Company.
Resignation effective November 27, 2023; no replacement named at this time.
Executive management and finance team will assume CFO duties.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jennifer Fox

Chief Financial Officer

NUVB · Nuvation Bio Inc.

Effective: 2023-11-27
Filed: November 13, 2023, 6:59 PM ET

On November 9, 2023, Jennifer Fox, the Chief Financial Officer of Nuvation Bio Inc. (the “Company”), notified the Company of her decision to pursue a new opportunity and resign from her position at the Company effective November 27, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jennifer Fox resigned as Chief Financial Officer at Nuvation Bio Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On November 9, 2023, Jennifer Fox, the Chief Financial Officer of Nuvation Bio Inc. (the “Company”), notified the Company of her decision to pursue a new opportunity and resign from her position at the Company effective November 27, 2023.

View on SEC.gov

Nuvation Bio Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-276021

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.